Early systematic approaches identified the strong association of MS with the MHC‐II allele HLA‐DRB1*1501 (Stewart et al. 1981), an indication that CD4+ T cells might be involved in disease evolution. The gene discussed is HLA-DRB1; the disease is myeloid sarcoma.